74 related articles for article (PubMed ID: 7101242)
1. Platelets, cardiac valves and sulphinpyrazone.
Loeliger EA
Thromb Haemost; 1982 Apr; 47(2):189. PubMed ID: 7101242
[No Abstract] [Full Text] [Related]
2. Proceedings: The effect of sulphinpyrazone (Anturan) on immunologically derived thrombocytopenia and on platelet survival.
White AM; Butler KD
Thromb Diath Haemorrh; 1975 Nov; 34(2):553-4. PubMed ID: 128152
[No Abstract] [Full Text] [Related]
3. Antiplatelet therapy.
Turpie AG
Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
[No Abstract] [Full Text] [Related]
4. Mechanisms of action of sulphinpyrazone.
Wallis RB
Thromb Res Suppl; 1983; 4():31-8. PubMed ID: 6415857
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of warfarin action by sulphinpyrazone.
Bailey RR; Reddy J
Lancet; 1980 Feb; 1(8162):254. PubMed ID: 6101699
[No Abstract] [Full Text] [Related]
6. Sulphinpyrazone and indomethacin for inhibition of platelet prostaglandin synthesis.
Huijgens PC; van den Berg CA; Imandt LM; Langenhuijsen MM
Thromb Res; 1981 Nov; 24(3):267-70. PubMed ID: 7336383
[No Abstract] [Full Text] [Related]
7. Sulphinpyrazone, aspirin, and uric acid.
Newland HR
Lancet; 1980 Apr; 1(8171):770. PubMed ID: 6103187
[No Abstract] [Full Text] [Related]
8. Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves.
Girolami A; Fabris F; Casonato A; Randi ML
Clin Lab Haematol; 1982; 4(1):23-6. PubMed ID: 7067372
[TBL] [Abstract][Full Text] [Related]
9. The effect of sulphinpyrazone and other drugs on the platelet response during the acute phase of the active Arthus reaction in guinea pigs.
Butler KD; Pay GF; Roberts JM; White AM
Thromb Res; 1979; 15(3-4):319-40. PubMed ID: 158844
[No Abstract] [Full Text] [Related]
10. [The pharmacology of sulfinpyrazone (Anturan)].
Rüegg M
Wien Med Wochenschr Suppl; 1980; 61():3-8. PubMed ID: 6930768
[No Abstract] [Full Text] [Related]
11. Platelet suppressant therapy in patients with prosthetic cardiac valves. Relationship of clinical effectiveness to alteration of platelet survival time.
Steele P; Rainwater J; Vogel R
Circulation; 1979 Oct; 60(4):910-3. PubMed ID: 476893
[TBL] [Abstract][Full Text] [Related]
12. Letter: Action of sulfinpyrazon.
de Jonge H; Loeliger EA
Thromb Diath Haemorrh; 1975 Jun; 33(3):674. PubMed ID: 1154325
[No Abstract] [Full Text] [Related]
13. On the inhibiting effect of sulfinpyrazone on platelets.
Cortellaro M; Polli EE
Thromb Res; 1979; 15(5-6):895-6. PubMed ID: 494186
[No Abstract] [Full Text] [Related]
14. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
Haas S; Ketterl R; Blümel G
Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
[TBL] [Abstract][Full Text] [Related]
15. [Platelet kinetics and diameter in heart valve diseases].
Dumoulin-Lagrange M; Tirmarche M; Horellou MH; Farah E; Acar J; Samama M
Nouv Presse Med; 1981 Jan; 10(1):42. PubMed ID: 7465342
[No Abstract] [Full Text] [Related]
16. A study of the effect of sulphinpyrazone ('Anturan') on blood viscosity.
Johnston RV; Lowe GD; Drummond MM; Forbes CD; Prentice CR
Curr Med Res Opin; 1979; 6(4):271-3. PubMed ID: 527353
[TBL] [Abstract][Full Text] [Related]
17. Sulfinpyrazone: relationship between dose, kinetics, plasma concentrations and biological effects.
Buchanan MR
Thromb Res Suppl; 1983; 4():89-92. PubMed ID: 6356467
[No Abstract] [Full Text] [Related]
18. Drug interactions and antiplatelet agents.
Ahmad S
Am J Cardiol; 1980 Aug; 46(2):341. PubMed ID: 7405849
[No Abstract] [Full Text] [Related]
19. The influence of pyrazole derivatives on blood platelets.
Fantl P
Aust J Exp Biol Med Sci; 1967 Aug; 45(4):355-62. PubMed ID: 6053584
[No Abstract] [Full Text] [Related]
20. Deleted in Malignant Brain Tumors 1 is up-regulated in bacterial endocarditis and binds to components of vegetations.
Müller H; Renner M; Helmke BM; End C; Weiss C; Poeschl J; Mollenhauer J
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):725-32. PubMed ID: 19698862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
